These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 32537658)

  • 1. Clinical pharmacy programmatic perspectives on use of direct-acting antivirals for acquired hepatitis C infection in solid organ transplant recipients.
    Crona L; Berry H; Byrns J; Campbell U
    Am J Health Syst Pharm; 2020 Jul; 77(14):1149-1152. PubMed ID: 32537658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to direct-acting antivirals for hepatitis C-negative transplant recipients receiving organs from hepatitis C-viremic donors.
    Bova S; Cameron A; Durand C; Katzianer J; LeGrand M; Boyer L; Glorioso J; Toman LP
    Am J Health Syst Pharm; 2022 Jan; 79(3):173-178. PubMed ID: 33987658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCV-infected solid organ donors, direct-acting antivirals and the current challenges.
    Fabrizi F; Cerutti R; Silva M
    Expert Rev Clin Pharmacol; 2020 Jan; 13(1):7-14. PubMed ID: 31786966
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcomes of hepatitis C virus seropositive donors to hepatitis C virus seronegative liver recipients: A large single center analysis.
    Sobotka LA; Mumtaz K; Wellner MR; Kelly SG; Conteh LF; Hanje AJ; Schenk A; El-Hinnawi A; Black S; Washburn K; Pesavento T; Daloul R; Michaels AJ
    Ann Hepatol; 2021; 24():100318. PubMed ID: 33515801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to hepatitis C direct-acting antiviral therapy in hepatitis C-positive donor to hepatitis C-negative recipient solid-organ transplantation in a real-world setting.
    Edmonds C; Carver A; DeClercq J; Choi L; Peter M; Schlendorf K; Perri R; Forbes RC; Concepcion BP
    Am J Surg; 2022 May; 223(5):975-982. PubMed ID: 34548142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C-positive donor to negative recipient kidney transplantation: A real-world experience.
    Jandovitz N; Nair V; Grodstein E; Molmenti E; Fahmy A; Abate M; Bhaskaran M; Teperman L
    Transpl Infect Dis; 2021 Jun; 23(3):e13540. PubMed ID: 33259125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the rational use of HCV+ organs worldwide.
    Morales JM; Sawinski D
    Clin Transplant; 2019 Dec; 33(12):e13739. PubMed ID: 31648391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Early Initiation of Direct-Acting Antiviral Therapy in Thoracic Organ Transplantation From Hepatitis C Virus Positive Donors.
    Smith DE; Chen S; Fargnoli A; Lewis T; Galloway AC; Kon ZN; Moazami N
    Semin Thorac Cardiovasc Surg; 2021; 33(2):407-415. PubMed ID: 32621962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Best practice recommendations for the use of hepatitis C viremic donor organs for hepatitis C virus naïve recipients.
    Stewart ZA; Shah SA; Rolls JA; Guarrera JV; Kandaswamy R; Axelrod DA
    Clin Transplant; 2021 Aug; 35(8):e14381. PubMed ID: 34086371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of organs from hepatitis C virus-viremic donors into uninfected recipients.
    Kahn JA
    Curr Opin Organ Transplant; 2020 Dec; 25(6):620-625. PubMed ID: 33105203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of hepatitis C virus-positive donors in kidney transplantation.
    Shetty A; Ariyamuthu VK; Gungor AB; Tanriover B
    Curr Opin Organ Transplant; 2023 Feb; 28(1):22-28. PubMed ID: 36227758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C viraemic organs in solid organ transplantation.
    Weinfurtner K; Reddy KR
    J Hepatol; 2021 Mar; 74(3):716-733. PubMed ID: 33212088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C donor positive to recipient negative solid organ transplants: Early direct acting antiviral insurance approval rates with and without documented viremia.
    Duong AT; Snyder HS; Billmeyer AL; Cox AC; Cheng NL; Ford RM; Fuller KG
    Am J Surg; 2023 Aug; 226(2):239-244. PubMed ID: 37137788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: Implications for therapeutic planning.
    Bethea E; Arvind A; Gustafson J; Andersson K; Pratt D; Bhan I; Thiim M; Corey K; Bloom P; Markmann J; Yeh H; Elias N; Kimura S; Dageforde LA; Cuenca A; Kawai T; Safa K; Williams W; Gilligan H; Sise M; Fishman J; Kotton C; Kim A; Rogers CC; Shao S; Cote M; Irwin L; Myoung P; Chung RT
    Am J Transplant; 2020 Jun; 20(6):1619-1628. PubMed ID: 31887236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of Clinician Opinions on Kidney Transplantation from Hepatitis C Virus Positive Donors: Identifying and Overcoming Barriers.
    Lentine KL; Peipert JD; Alhamad T; Caliskan Y; Concepcion BP; Forbes R; Schnitzler M; Chang SH; Cooper M; Bloom RD; Mannon RB; Axelrod DA
    Kidney360; 2020 Nov; 1(11):1291-1299. PubMed ID: 33251523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Outcomes of Multivisceral Transplant Using Hepatitis C-Positive Donors.
    McMaster WG; Rahaman ZM; Shipe ME; Quintana EN; Sandhaus EM; Smith SS; Crockett JE; Forbes RC; Schlendorf KH; Shah AS
    Ann Thorac Surg; 2021 Aug; 112(2):511-518. PubMed ID: 33121968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding access to transplantation with hepatitis C-positive donors: A new perspective on an old issue.
    Kling CE; Limaye AP; Landis CS; Sibulesky L
    Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 28130837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidisciplinary practice advancement: Role of a clinical pharmacy specialist in a pediatric specialty clinic.
    Lynton JJ; Mersch A; Ferguson PJ
    Am J Health Syst Pharm; 2020 Oct; 77(21):1771-1777. PubMed ID: 32789458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of hepatitis C viremic donors for liver transplant recipients without hepatitis C. A veterans transplant center report.
    Said A; Weiss M; Varhelyi A; Farago R; Ballweg C; Rice J; Agarwal P; Fernandez L; Foley D
    Transpl Infect Dis; 2021 Apr; 23(2):e13466. PubMed ID: 32931616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing a multidisciplinary HCV direct-acting antivirals utilization management and assessment program.
    Ajlan AA; Al-Gain R; Ahmed M; Abu-Riash T; Alquaiz M; Alkhail FA; Alashgar H; Alkhairallah T; Alkortas D; Al-Jedai A
    J Am Pharm Assoc (2003); 2021; 61(2):e159-e170. PubMed ID: 33309191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.